entertainment -WSS

entertainment

author：focus 2025-09-27 12:56:09 - browse：194

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Clinical trials must include more disabled people

explore

WSS

Study links childhood stress with decline in older age

Evacuations in place as 3 wildfires burn in eastern Washington state

The pain doctors face in trying to build their families

Pharma showers House GOP doctor with campaign cash

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

FDA scientists endorse Pfizer/BioNTech Covid

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Virginia high school admissions case could be legal follow

Biotech startup Celsius cuts 75% of staff ahead of first trial start

As demand for Covid shots wanes, Moderna seeks its next success

ActiGraph execs on goal of drug approvals with digital endpoints

United colonoscopy coverage change 'may cost lives,' doctors say

New definition of a human embryo proposed amid rapid advances

Walensky prepares to leave CDC — and Congress — behind

How I helped Pfizer think through the ethics of Viagra

knowledge

Clinical trials must include more disabled people

New definition of a human embryo proposed amid rapid advances

As Maui death toll rises, number of missing remains unclear

Patient advocates sound warning on FDA proposal on salt intake

Congress must give Medicare recipients genetic counseling access

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

explore

explore

entertainment